BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 9181129)

  • 1. [Genetic control of the development by retinoic acid].
    Mark M; Kastner P; Ghyselinck NB; Krezel W; Dupé V; Chambon P
    C R Seances Soc Biol Fil; 1997; 191(1):77-90. PubMed ID: 9181129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of retinoic acid receptor beta isoforms to the formation of the conotruncal septum of the embryonic heart.
    Ghyselinck NB; Wendling O; Messaddeq N; Dierich A; Lampron C; Décimo D; Viville S; Chambon P; Mark M
    Dev Biol; 1998 Jun; 198(2):303-18. PubMed ID: 9659935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the retinoic acid receptor beta (RARbeta) during mouse development.
    Ghyselinck NB; Dupé V; Dierich A; Messaddeq N; Garnier JM; Rochette-Egly C; Chambon P; Mark M
    Int J Dev Biol; 1997 Jun; 41(3):425-47. PubMed ID: 9240560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
    Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
    J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of retinoic acid receptor gamma to retinoid-induced craniofacial and axial defects.
    Iulianella A; Lohnes D
    Dev Dyn; 1997 May; 209(1):92-104. PubMed ID: 9142499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of the retinoic acid receptor gamma directly induces terminal differentiation of human embryonal carcinoma cells.
    Moasser MM; Reuter VE; Dmitrovsky E
    Oncogene; 1995 Apr; 10(8):1537-43. PubMed ID: 7731708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
    Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
    Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different response to retinoic acid of two teratocarcinoma cell lines.
    Wan YJ; Wang L; Wu TC
    Exp Cell Res; 1995 Aug; 219(2):392-8. PubMed ID: 7543852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
    Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL
    J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic footprinting of retinoic acid regulated promoters in embryonal carcinoma cells.
    Dey A; Ozato K
    Methods; 1997 Feb; 11(2):197-204. PubMed ID: 8993032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers.
    Lotan R
    Anticancer Res; 1996; 16(4C):2415-9. PubMed ID: 8816844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesectoderm is a major target of retinoic acid action.
    Mark M; Ghyselinck NB; Kastner P; Dupé V; Wendling O; Krezel W; Mascrez B; Chambon P
    Eur J Oral Sci; 1998 Jan; 106 Suppl 1():24-31. PubMed ID: 9541199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the factors involved in the retinoic acid-induced differentiation of a retinoid-hypersensitive embryonal carcinoma cell mutant.
    Dietrich JM; McCormick PJ
    Exp Cell Res; 1994 Feb; 210(2):201-8. PubMed ID: 8299717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivation and characterization of retinoid-resistant human embryonal carcinoma cells.
    Moasser MM; Khoo KS; Maerz WJ; Zelenetz A; Dmitrovsky E
    Differentiation; 1996 Jul; 60(4):251-7. PubMed ID: 8765055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic dissection of retinoic acid function in epidermis physiology].
    Ghyselinck NB; Chapellier B; Calléja C; Kumar Indra A; Li M; Messaddeq N; Mark M; Metzger D; Chambon P
    Ann Dermatol Venereol; 2002 May; 129(5 Pt 2):793-9. PubMed ID: 12223961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited specificity and large overlap of the functions of the mouse RAR gamma 1 and RAR gamma 2 isoforms.
    Subbarayan V; Kastner P; Mark M; Dierich A; Gorry P; Chambon P
    Mech Dev; 1997 Aug; 66(1-2):131-42. PubMed ID: 9376317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retinoid signalling pathways].
    Fukasawa H; Shudo K
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):555-66. PubMed ID: 8470912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells.
    Lehmann S; Paul C; Törmä H
    Clin Cancer Res; 2001 Feb; 7(2):367-73. PubMed ID: 11234892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of retinoic acid (RA) receptor mRNAs in the fetal mouse secondary palate by all-trans and 13-cis RAs: implications for RA-induced teratogenesis.
    Naitoh H; Mori C; Nishimura Y; Shiota K
    J Craniofac Genet Dev Biol; 1998; 18(4):202-10. PubMed ID: 10100049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma.
    Elmazar MM; Reichert U; Shroot B; Nau H
    Teratology; 1996 Mar; 53(3):158-67. PubMed ID: 8761883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.